Urinary autotaxin concentrations are associated with kidney injury.

[1]  M. Sumitani,et al.  Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model , 2019, Scientific Reports.

[2]  V. Aidinis,et al.  Autotaxin and chronic inflammatory diseases. , 2019, Journal of autoimmunity.

[3]  P. Little,et al.  Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease. , 2019, Pharmacology & therapeutics.

[4]  H. Jun,et al.  Lysophosphatidic Acid Signaling in Diabetic Nephropathy , 2019, International journal of molecular sciences.

[5]  S. Kihara,et al.  Serum autotaxin levels are associated with Graves' disease. , 2019, Endocrine journal.

[6]  M. Kurano,et al.  Lysophospholipids in laboratory medicine , 2018, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[7]  K. Koike,et al.  Performance of autotaxin as a serum marker for liver fibrosis , 2018, Annals of clinical biochemistry.

[8]  M. Kurano,et al.  Association between serum autotaxin or phosphatidylserine‐specific phospholipase A1 levels and melanoma , 2018, The Journal of dermatology.

[9]  N. Tanaka,et al.  Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease , 2018, World journal of gastroenterology.

[10]  M. Ota,et al.  Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[11]  M. Kurano,et al.  Role of the Autotaxin-LPA Pathway in Dexamethasone-Induced Fibrotic Responses and Extracellular Matrix Production in Human Trabecular Meshwork Cells. , 2018, Investigative ophthalmology & visual science.

[12]  Silvia Anahi Valdés-Rives,et al.  Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development , 2017, Mediators of inflammation.

[13]  R. Harris,et al.  Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model. , 2017, Journal of the American Society of Nephrology : JASN.

[14]  Duane D. Miller,et al.  Role of lysophosphatidic acid and its receptors in the kidney. , 2017, Physiological genomics.

[15]  H. Jun,et al.  Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice. , 2017, Kidney international.

[16]  Maria João Pires,et al.  Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies. , 2017, In vivo.

[17]  J. Schanstra,et al.  Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: potential involvement in chronic kidney disease , 2016, Journal of Physiology and Biochemistry.

[18]  F. Lammert,et al.  Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases , 2016, Scientific Reports.

[19]  S. Kaneko,et al.  Serum Autotaxin Levels Are Associated with Proteinuria and Kidney Lesions in Japanese Type 2 Diabetic Patients with Biopsy-proven Diabetic Nephropathy. , 2016, Internal medicine.

[20]  Y. Yung,et al.  Lysophosphatidic acid signalling in development , 2015, Development.

[21]  H. Daida,et al.  Possible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[22]  T. Shigematsu,et al.  A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy , 2014, Diabetology International.

[23]  Y. Yung,et al.  LPA receptor signaling: pharmacology, physiology, and pathophysiology , 2014, Journal of Lipid Research.

[24]  T. Ninomiya,et al.  Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes , 2014, Clinical and Experimental Nephrology.

[25]  W. Moolenaar,et al.  Autotaxin in embryonic development. , 2013, Biochimica et biophysica acta.

[26]  H. Ikeda,et al.  Autotaxin in liver fibrosis. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[27]  S. Kōzuma,et al.  Serum autotaxin measurements in pregnant women: application for the differentiation of normal pregnancy and pregnancy-induced hypertension. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[28]  M. Kurokawa,et al.  Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma , 2008, British journal of haematology.

[29]  Julie Klein,et al.  Lysophosphatidic acid and renal fibrosis. , 2008, Biochimica et biophysica acta.

[30]  Y. Yatomi,et al.  Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity , 2008, Annals of clinical biochemistry.

[31]  M. Nangaku,et al.  Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[32]  M. Nangaku,et al.  Analysis of serum and urinary lysophospholipase D/autotaxin in nephrotic syndrome , 2008, Clinical chemistry and laboratory medicine.

[33]  J. Chun,et al.  LPA1 receptor activation promotes renal interstitial fibrosis. , 2007, Journal of the American Society of Nephrology : JASN.

[34]  M. Omata,et al.  Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity. , 2007, Life sciences.

[35]  H. Ikeda,et al.  Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids. , 2007, Analytical biochemistry.

[36]  H. Arai,et al.  Measurement of lysophospholipase D/autotaxin activity in human serum samples. , 2007, Clinical biochemistry.

[37]  Y. Yatomi,et al.  Lysophospholipase D activity exists in the urine to catalyse the formation of lysophosphatidic acid. , 2006, Nephrology, Dialysis and Transplantation.

[38]  L. Liotta,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.